Species |
Mouse&Human |
Protein Construction |
Chimeric Integrin alpha V beta 6 (ITGAV&ITGB6) Heterodimer [Phe31-Val988 (ITGAV) acidic tail and Gly22-Asn707 (ITGB6) basic tail] Accession # P43406(ITGAV)&P18564-1(ITGB6) Phe31-Val988 (ITGAV) acidic tail and Gly22-Asn707 (ITGB6) basic tail) Accession # P43406(ITGAV)&P18564-1(ITGB6) |
His |
N-term |
C-term |
|
Purity |
> 95% as determined by BisTris PAGE > 95% as determined by HPLC |
Endotoxin Level |
Less than 1EU per μg by the LAL method. |
Biological Activity |
Measured by its binding ability in a functional ELISA. Immobilized Chimeric Integrin alpha V beta 6 (ITGAV&ITGB6) Heterodimer, His, Mouse&Human at 2μg/ml (100μl/well) on the plate can bind Biotinylated Human Latent TGF beta 1, His Tag. Test result was comparable to standard batch. |
Expression System |
HEK293 |
Theoretical Molecular Weight |
131.48 kDa (ITGAV) and 79.1 kDa (ITGB6) |
Apparent Molecular Weight |
Due to glycosylation, the protein migrates to 120-160 kDa (ITGAV) and 90-120 kDa (ITGB6) based on Bis-Tris PAGE result. |
Formulation |
Lyophilized from 0.22 μm filtered solution in PBS (pH 7.4). |
Reconstitution |
Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water. |
Storage & Stability |
Upon receiving, the product remains stable up to 6 months at -20 °C or below. Upon reconstitution, the product should be stable for 3 months at -80 °C. Avoid repeated freeze-thaw cycles. |
Target Background |
ITGAV&ITGB6 is a receptor for fibronectin and cytotactin. It recognizes the sequence R-G-D in its ligands. Internalisation of integrin alpha-V/beta-6 via clathrin-mediated endocytosis promotes carcinoma cell invasion. ITGAV&ITGB6 acts as a receptor for fibrillin-1 (FBN1) and mediates R-G-D-dependent cell adhesion to FBN1. |
Synonyms |
αVβ6; Integrin alpha V beta 6; ITGAV&ITGB6;Integrin alpha V β 6 |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.